Imunon, Inc. — Director's Dealing 2012

Dec 19, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Celsion CORP (CLSN)
CIK: 0000749647
Period of Report: 2012-12-18

Reporting Person: WEAVER GREGORY L (SVP & Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-12-18	Celsion Corporation Common Stock	M	8636	$2.77	Acquired	37272	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-12-18	Warrants to purchase Celsion Corporation Common Stock	$2.77	X	8636	Disposed	2017-11-25	Celsion Corporation Common Stock (8636)	Direct

Footnotes

F1: The Officer purchased Celsion Corporation Common Stock through the exercise of warrants obtained in the May 2011 PIPE Stock Offering. These warrants were fully exercisable with an exercise price of $2.77 per share. The Officer has no immediate intent to sell these newly acquired shares.